Chia-Lin Simmons - 14 Jun 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRO	Stock Option	Award		+90,000	+600%		105,000	14 Jun 2024	Common Stock	90,000	$1.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	On June 14, 2024, the Reporting Person was granted stock options to purchase 90,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.